A phase II study of induction chemotherapy with gemcitabine (G) and cisplatin (P) in locally advanced non-small cell lung cancer: Interim analysis

Lung Cancer

Volumn 34, Issue SUPPL. 4, 2001, Pages 15-20

  Santo, Antonio ^a   Pedersini, R ^a   Pasini, F ^a   Terzi, A ^b   Pari, F ^c   Cartei, G ^d   Sibau, A ^e   Molino, A ^a   Maiorino, A ^f   Panza, N ^g   Oletti, M V ^h   Maluta, S ^b   Calabro F ^b   Cetto, G L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Azienda Ospedaliera   (Italy)

^c Division of Medical Oncology   (Italy)

^d CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^e UNIVERSITY HOSPITAL OF UDINE   (Italy)

^f OC Monaldi   (Italy)

^g Medical Oncology   (Italy)

^h Division of Medical Oncology   (Italy)

Author keywords

Gemcitabine cisplatin combination; Multimodality therapy; Neoadjuvant chemotherapy; Non small cell lung cancer; Phase II study

Indexed keywords

CISPLATIN; CORTICOSTEROID; GEMCITABINE; MAGNESIUM SULFATE; POTASSIUM CHLORIDE;

ADULT; ADVANCED CANCER; AGED; ANEMIA; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DYSPNEA; FEMALE; FLU LIKE SYNDROME; HUMAN; INFECTION; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PARESTHESIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA;

EID: 0035195406     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(01)00400-7     Document Type: Conference Paper

References (33)

1. Future direction in the treatment of non-small-cell lung cancer, department of Medicine, Toronto Hospital Ontario, Canada
2. The role of Neoadjuvant chemotherapy in NSCLC
3. Improved survival in stage III non-small-cell lung cancer: seven years follow up of cancer and leukemia group B (CALGB) 8433 Trial
4. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma
5. The role of surgery in N2 lung cancer
6. Advances in the treatment of NSCLC
7. Neoadjuvant chemotherapy of non small cell bronchial cancers
8. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis
9. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer
10. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer
11. Preoperative chemotherapy for stage IIIA (N2) lung cancer: the Sloan Kettering experience with 136 patients
12. Neoadiuvant treatment of stage IIIA non small cell lung cancer: long term results
13. Induction chemotherapy with MVP on patients with stage IIIA (T1-3, N2, M0) unresectable non small cell lung cancer (NSCLC): the Toronto experience
14. Gemcitabine+cisplatin versus etoposide+cisplatin in advanced non small cell lung cancer patients: preliminary randomized phase III results
15. Weekly Gemcitabine with monthly Cisplatin: effective chemotherapy for advanced non-small-cell lung cancer
16. Cisplatin-Gemcitabine combination in advanced non-small-cell lung cancer: a phase II study
17. Gemcitabin (G) and Platin (P) in advanced non-small-cell lung cancer (NSCLC): a phase II study with emphasis on intention-to-treat analysis
18. Phase III trial of Gemcitabine plus Cisplatin versus Cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer
19. Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer
20. Gemcitabine and Cisplatin versus Mitomycin, Ifosfamide, and Cisplatin in advanced non-small-cell lung cancer: a randomized phase III study of the Italian Lung Cancer Project
21. The activity of Gemcitabine plus Cisplatin in randomized trial in untreated patients with advanced non-small cell lung cancer
22. Gemcitabine/Cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer
23. Phase II study of Gemcitabine plus Cisplatin as induction regimen for patients with stage IIIA-IIIB non-small-cell lung cancer
24. A phase II feasability trial of Gemcitabine and Cisplatin before local treatment in locally advanced Non-Small Cell Lung Cancer
25. Induction chemotherapy with Gemcitabine and Cisplatin in locally advanced stage III non-small cell lung cancer. A phase II study
26. Gemcitabine and Cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European organization for research and treatment of cancer lung cancer cooperative group (EORTC 08955)
27. Combined Cisplatin and Gemcitabine for non-small cell lung cancer: influence of scheduling on toxicity and drug delivery
28. Preoperative chemotherapy (CHT) with Cisplatin and Gemcitabine in locally advanced (LA) unresectable non-small-cell lung cancer
29. A phase II trial of high-dose Gemcitabine (GEM), Cisplatin (CDDP) and sequential radiotherapy for unresectable stage III non small cell lung cancer (NSCLC). Preliminary results
30. Gemcitabine and Cisplatin as induction chemotherapy in stage IIIA N2/IIIB non small cell lung cancer (NSCLC). A mono-institutional phase II study with a 21 days schedule